Injection of PRP (Platelet-rich plasma) as a treatment for androgenetic alopecia : a systematic review of the literature

2018 ◽  
Vol 39 (5) ◽  
pp. 438-446 ◽  
Author(s):  
O Oth ◽  
JJ Stene ◽  
R Glineur ◽  
A Vujovic
2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Pooneh Torabi ◽  
Elham Behrangi ◽  
Azadeh Goodarzi ◽  
Masoomeh Rohaninasab

2019 ◽  
Vol 32 (3) ◽  
Author(s):  
Torello Lotti ◽  
Andy Goren ◽  
Ines Verner ◽  
Patrizia A. D'Alessio ◽  
Katlein Franca

Medicina ◽  
2021 ◽  
Vol 57 (4) ◽  
pp. 311
Author(s):  
Santo Raffaele Mercuri ◽  
Giovanni Paolino ◽  
Matteo Riccardo Di Nicola ◽  
Laura Vollono

Background: female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in women, affecting approximately 40% of women by age 50, bearing a significant psychosocial burden on affected patients. Platelet-rich plasma (PRP) has been widely investigated as a potential effective treatment for several dermatological conditions, including male androgenetic alopecia (MAGA). However, few studies have been conducted focusing on the use of PRP in FAGA. The aim of this review was to identify reports that investigated the use of PRP for the treatment of FAGA. Methods: Electronic databases of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to September 2020 have been searched using different combinations of the following terms: “androgenetic alopecia,” “FAGA,” “female pattern hair loss,” “platelet-rich fibrin,” “platelet-rich plasma,” and “PRP”. Results and conclusions: Eight (n = 8) clinical studies consistent with our research were identified. A total of 197 subjects has been enrolled in the included studies. All of them were adult female patients (mean age: 38.9) affected by female pattern hair loss. PRP is a well-tolerated procedure which showed promising results in males-only and mixed populations of AGA patients. PRP showed to produce high levels of satisfaction and improvement in the quality of life in patients affected by FAGA. In the light of this evidence, PRP may be proposed in patients who did not respond or did not tolerate topical minoxidil, as well as in combination with topical and oral treatments.


2017 ◽  
Vol 4 (1) ◽  
pp. 1-11 ◽  
Author(s):  
Jessica Cervantes ◽  
Marina Perper ◽  
Lulu L. Wong ◽  
Ariel E. Eber ◽  
Alexandra C. Villasante Fricke ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document